2019 Interagency Autism Coordinating Committee Call for Nominations Announcement, 65165-65166 [2019-25668]
Download as PDF
Federal Register / Vol. 84, No. 228 / Tuesday, November 26, 2019 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
2019 Interagency Autism Coordinating
Committee Call for Nominations
Announcement
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The Office of the Secretary of
the Department of Health and Human
Services (HHS) is seeking nominations
of individuals to serve as non-federal
public members on the Interagency
Autism Coordinating Committee (IACC).
DATES: Nominations will be accepted
between Wednesday, November 13,
2019 and Friday, January 17, 2020.
ADDRESSES: Nominations are due by
Friday January 17, 2020 and may be sent
to Dr. Susan Daniels, Director, Office of
Autism Research Coordination/NIMH/
NIH, 6001 Executive Boulevard, Room
7220, Bethesda, Maryland 20892 by
standard or express mail, or via email to
IACCPublicInquiries@mail.nih.gov.
Confirmation of receipt will be
provided. More information about the
IACC is available at iacc.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Susan Daniels at 301–827–1437 or email
at iaccpublicinquiries@mail.nih.gov.
SUPPLEMENTARY INFORMATION: As
specified in the Combating Autism Act
of 2006 (Pub. L. 109–416) and
reauthorized by the Autism
Collaboration, Accountability, Research,
Education and Support Act of 2019
(Pub. L. 116–60). The Office of the
Secretary has directed the Office of
Autism Research Coordination (OARC)
of the National Institute of Mental
Health, National Institutes of Health to
assist the Department in conducting an
open nomination process.
Appointments of non-federal public
members to the committee shall be
made by the Secretary of Health and
Human Services.
SUMMARY:
Eligibility Requirements
Nominations of new non-federal
public members are encouraged, and
current non-federal public members
may also be re-nominated to continue to
serve if they have served only one term
previously, in accordance with the
provisions of the Autism CARES Act of
2019. Self-nominations and
nominations of other individuals are
both permitted. Only one nomination
per individual is required. Multiple
nominations of the same individual will
not increase likelihood of selection. The
Secretary may select non-federal public
VerDate Sep<11>2014
16:47 Nov 25, 2019
Jkt 250001
members from the pool of submitted
nominations and other sources as
needed to meet statutory requirements
and to form a balanced committee that
represents the diversity within the
autism spectrum disorder (ASD)
community.
Those eligible for nomination include
individuals on the autism spectrum,
parents or guardians of individuals with
ASD, leaders or representatives of major
ASD research, advocacy and service
organizations, healthcare and service
providers, educators, researchers and
other individuals with professional or
personal experience with ASD.
Nominations of individuals with a
variety of disability and support needs,
individuals from all U.S. states and
territories, and individuals representing
diverse populations within the autism
community, including all genders and
gender identities, cultural, ethnic and
racial groups are encouraged. Requests
for reasonable accommodation to enable
participation on the Committee should
be indicated in the nomination
submission.
IACC non-federal public members are
appointed as special government
employees and are required to be U.S.
citizens. To serve, they must submit an
annual confidential financial disclosure
report used to determine conflicts of
interest as well as a foreign activities
questionnaire. Prohibited foreign
activities include holding a position or
title with a foreign governmental entity
(including certain universities), and
from receiving compensation and
certain gifts from a foreign government.
In accordance with White House Office
of Management and Budget guidelines
(FR Doc. 2014–19140), federallyregistered lobbyists are not eligible.
Federal employees may not serve as
non-federal public members. IACC nonfederal public members may be
restricted from serving on other federal
advisory committees while serving on
the IACC. Male non-federal public
members must have signed up for the
U.S. Selective Service in order to be
eligible.
Responsibilities of Appointed NonFederal Public Members
As specified in the Committee’s
authorizing statute (section 399CC of the
Public Health Service Act, 42 U.S.C.
280i–2, as amended), the Committee
will carry out the following
responsibilities: (1) Monitor autism
spectrum disorder research, and to the
extent practicable, services and support
activities, across all relevant Federal
departments and agencies, including
coordination of Federal activities with
respect to autism spectrum disorder; (2)
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
65165
develop a summary of advances in
autism spectrum disorder research
related to causes, prevention, treatment,
early screening, diagnosis or ruling out
a diagnosis; interventions, including
school and community-based
interventions, and access to services and
supports for individuals with autism
spectrum disorder across the lifespan of
such individuals; (3) make
recommendations to the Secretary
regarding any appropriate changes to
such activities, including with respect
to the strategic plan; (4) make
recommendations to the Secretary
regarding public participation in
decisions relating to autism spectrum
disorder, and the process by which
public feedback can be better integrated
into such decisions; (5) develop a
strategic plan for the conduct of, and
support for, autism spectrum disorder
research, including, as practicable, for
services and supports, for individuals
with an autism spectrum disorder across
the lifespan of such individuals and the
families of such individuals, which
shall include (A) proposed budgetary
requirements; and (B) recommendations
to ensure that autism spectrum disorder
research, and services and support
activities to the extent practicable, of the
Department of Health and Human
Services and of other Federal
departments and agencies are not
unnecessarily duplicative; and (6)
submit to Congress and the President:
(A) An annual update on the summary
of advances; and (B) an annual update
to the strategic plan, including any
progress made in achieving the goals
outlined in such strategic plan.
Committee Composition
In accordance with the Committee’s
authorizing statute, ‘‘Not more than 1⁄2,
but not fewer than 1⁄3, of the total
membership of the Committee shall be
composed of non-Federal public
members appointed by the Secretary.’’
All non-Federal public members are
appointed as Special Government
Employees for their service on the IACC,
of which:
• At least three such members shall
be individuals with a diagnosis of
autism spectrum disorder;
• At least three such members shall
be parents or legal guardians of an
individual with an autism spectrum
disorder; and
• At least three such members shall
be representatives of leading research,
advocacy, and service organizations for
individuals with autism spectrum
disorder.
The Department strives to ensure that
the membership of HHS Federal
advisory committees is balanced in
E:\FR\FM\26NON1.SGM
26NON1
65166
Federal Register / Vol. 84, No. 228 / Tuesday, November 26, 2019 / Notices
terms of points of view represented and
the committee’s function. Every effort is
made to ensure that diverse views and
perspectives are represented on HHS
Federal advisory committees and,
therefore, the Department encourages
nominations of qualified candidates of
all genders, cultural, ethnic, and racial
groups, people with disabilities, and
individuals who may belong to other
underrepresented groups. The
Department also seeks geographic
diversity in the composition of the
Committee. Appointment to this
Committee shall be made without
discrimination on the basis of age, race,
ethnicity, gender, sexual orientation,
disability, and cultural, religious, or
socioeconomic status. Requests for
reasonable accommodation to enable
participation on the Committee should
be indicated in the nomination
submission.
requirements met, disability
accommodation requests, and an
indication of commitment to attend
IACC meetings if selected, as well as full
contact information and a current
resume or curriculum vitae. Up to 2
letters of support are permitted in
addition to the nomination, with a page
limit of 3 pages per letter. Please do not
include other materials unless
requested.
Nominations are due by Friday
January 17, 2020 and may be sent to Dr.
Susan Daniels, Director, Office of
Autism Research Coordination/NIMH/
NIH, 6001 Executive Boulevard, Room
7220, Bethesda, Maryland 20892 by
standard or express mail, or via email to
IACCPublicInquiries@mail.nih.gov.
Confirmation of receipt will be
provided.
More information about the IACC is
available at iacc.hhs.gov.
Member Terms
Non-Federal public members of the
Committee ‘‘shall serve for a term of 4
years, and may be reappointed for one
additional 4-year term. Any member
appointed to fill a vacancy for an
unexpired term shall be appointed for
the remainder of such term. A member
[with a valid appointment] may serve
after the expiration of the member’s
term until a successor has been
appointed.’’
Dated: November 20, 2019.
Susan A. Daniels,
Director, Office of Autism Research
Coordination, National Institute of Mental
Health, National Institutes of Health.
Meetings and Travel
‘‘The Committee shall meet at the call
of the chairperson or upon the request
of the Secretary. The Committee shall
meet not fewer than 2 times each year.’’
In the years 2014–2019, the IACC held
an average of 4 meetings, 1 workshop
and 2 phone conferences per year,
including full committee,
subcommittee, working and planning
group meetings, and workshops. Travel
expenses are provided for non-federal
public Committee members to facilitate
attendance at in-person meetings.
Members are expected to be committed
to making every effort to attend all full
committee meetings and workshops in
person and relevant subcommittee,
working and planning group meetings
by phone. For those who occasionally
cannot travel or for individuals with a
disability that prevents travel, remote
access options are provided.
Submission Instructions and Deadline
Nominations should include a cover
letter of no longer than 3 pages
describing the candidate’s interest in
seeking appointment to the IACC,
including relevant personal and
professional experience with ASD,
indication of any membership eligibility
VerDate Sep<11>2014
16:47 Nov 25, 2019
Jkt 250001
[FR Doc. 2019–25668 Filed 11–25–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel RFA Panel:
Tobacco Regulatory Science C.
Date: December 19, 2019.
Time: 10:30 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kristen Prentice, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Health, 6701 Rockledge Drive, Room 3112,
MSC 7808, Bethesda, MD 20892, 301–496–
0726, prenticekj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 20, 2019
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–25593 Filed 11–25–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The invention listed below is
owned by an agency of the U.S.
Government and is available for
licensing to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
FOR FURTHER INFORMATION CONTACT:
Dianca Finch, Ph.D., 240–669–5503;
dianca.finch@nih.gov. Licensing
information and copies of the U.S.
patent application listed below may be
obtained by communicating with the
indicated licensing contact at the
Technology Transfer and Intellectual
Property Office, National Institute of
Allergy and Infectious Diseases, 5601
Fishers Lane, Rockville, MD, 20852; tel.
301–496–2644. A signed Confidential
Disclosure Agreement will be required
to receive copies of unpublished patent
applications.
SUPPLEMENTARY INFORMATION:
Technology description follows:
SUMMARY:
A High-Yield Perfusion-Based
Transient Gene Expression Bioprocess
Description of Technology
Currently, fed-batch processes are the
most commonly used bioprocesses in
transient gene expression (TGE) vaccine
manufacturing. However, because fedbatch processes keep all the cells and
protein product in the vessel throughout
the run, some limitations are intrinsic.
First, waste products like cell debris or
E:\FR\FM\26NON1.SGM
26NON1
Agencies
[Federal Register Volume 84, Number 228 (Tuesday, November 26, 2019)]
[Notices]
[Pages 65165-65166]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-25668]
[[Page 65165]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
2019 Interagency Autism Coordinating Committee Call for
Nominations Announcement
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Office of the Secretary of the Department of Health and
Human Services (HHS) is seeking nominations of individuals to serve as
non-federal public members on the Interagency Autism Coordinating
Committee (IACC).
DATES: Nominations will be accepted between Wednesday, November 13,
2019 and Friday, January 17, 2020.
ADDRESSES: Nominations are due by Friday January 17, 2020 and may be
sent to Dr. Susan Daniels, Director, Office of Autism Research
Coordination/NIMH/NIH, 6001 Executive Boulevard, Room 7220, Bethesda,
Maryland 20892 by standard or express mail, or via email to
[email protected]. Confirmation of receipt will be
provided. More information about the IACC is available at iacc.hhs.gov.
FOR FURTHER INFORMATION CONTACT: Susan Daniels at 301-827-1437 or email
at [email protected]
SUPPLEMENTARY INFORMATION: As specified in the Combating Autism Act of
2006 (Pub. L. 109-416) and reauthorized by the Autism Collaboration,
Accountability, Research, Education and Support Act of 2019 (Pub. L.
116-60). The Office of the Secretary has directed the Office of Autism
Research Coordination (OARC) of the National Institute of Mental
Health, National Institutes of Health to assist the Department in
conducting an open nomination process. Appointments of non-federal
public members to the committee shall be made by the Secretary of
Health and Human Services.
Eligibility Requirements
Nominations of new non-federal public members are encouraged, and
current non-federal public members may also be re-nominated to continue
to serve if they have served only one term previously, in accordance
with the provisions of the Autism CARES Act of 2019. Self-nominations
and nominations of other individuals are both permitted. Only one
nomination per individual is required. Multiple nominations of the same
individual will not increase likelihood of selection. The Secretary may
select non-federal public members from the pool of submitted
nominations and other sources as needed to meet statutory requirements
and to form a balanced committee that represents the diversity within
the autism spectrum disorder (ASD) community.
Those eligible for nomination include individuals on the autism
spectrum, parents or guardians of individuals with ASD, leaders or
representatives of major ASD research, advocacy and service
organizations, healthcare and service providers, educators, researchers
and other individuals with professional or personal experience with
ASD. Nominations of individuals with a variety of disability and
support needs, individuals from all U.S. states and territories, and
individuals representing diverse populations within the autism
community, including all genders and gender identities, cultural,
ethnic and racial groups are encouraged. Requests for reasonable
accommodation to enable participation on the Committee should be
indicated in the nomination submission.
IACC non-federal public members are appointed as special government
employees and are required to be U.S. citizens. To serve, they must
submit an annual confidential financial disclosure report used to
determine conflicts of interest as well as a foreign activities
questionnaire. Prohibited foreign activities include holding a position
or title with a foreign governmental entity (including certain
universities), and from receiving compensation and certain gifts from a
foreign government. In accordance with White House Office of Management
and Budget guidelines (FR Doc. 2014-19140), federally-registered
lobbyists are not eligible. Federal employees may not serve as non-
federal public members. IACC non-federal public members may be
restricted from serving on other federal advisory committees while
serving on the IACC. Male non-federal public members must have signed
up for the U.S. Selective Service in order to be eligible.
Responsibilities of Appointed Non-Federal Public Members
As specified in the Committee's authorizing statute (section 399CC
of the Public Health Service Act, 42 U.S.C. 280i-2, as amended), the
Committee will carry out the following responsibilities: (1) Monitor
autism spectrum disorder research, and to the extent practicable,
services and support activities, across all relevant Federal
departments and agencies, including coordination of Federal activities
with respect to autism spectrum disorder; (2) develop a summary of
advances in autism spectrum disorder research related to causes,
prevention, treatment, early screening, diagnosis or ruling out a
diagnosis; interventions, including school and community-based
interventions, and access to services and supports for individuals with
autism spectrum disorder across the lifespan of such individuals; (3)
make recommendations to the Secretary regarding any appropriate changes
to such activities, including with respect to the strategic plan; (4)
make recommendations to the Secretary regarding public participation in
decisions relating to autism spectrum disorder, and the process by
which public feedback can be better integrated into such decisions; (5)
develop a strategic plan for the conduct of, and support for, autism
spectrum disorder research, including, as practicable, for services and
supports, for individuals with an autism spectrum disorder across the
lifespan of such individuals and the families of such individuals,
which shall include (A) proposed budgetary requirements; and (B)
recommendations to ensure that autism spectrum disorder research, and
services and support activities to the extent practicable, of the
Department of Health and Human Services and of other Federal
departments and agencies are not unnecessarily duplicative; and (6)
submit to Congress and the President: (A) An annual update on the
summary of advances; and (B) an annual update to the strategic plan,
including any progress made in achieving the goals outlined in such
strategic plan.
Committee Composition
In accordance with the Committee's authorizing statute, ``Not more
than \1/2\, but not fewer than \1/3\, of the total membership of the
Committee shall be composed of non-Federal public members appointed by
the Secretary.''
All non-Federal public members are appointed as Special Government
Employees for their service on the IACC, of which:
At least three such members shall be individuals with a
diagnosis of autism spectrum disorder;
At least three such members shall be parents or legal
guardians of an individual with an autism spectrum disorder; and
At least three such members shall be representatives of
leading research, advocacy, and service organizations for individuals
with autism spectrum disorder.
The Department strives to ensure that the membership of HHS Federal
advisory committees is balanced in
[[Page 65166]]
terms of points of view represented and the committee's function. Every
effort is made to ensure that diverse views and perspectives are
represented on HHS Federal advisory committees and, therefore, the
Department encourages nominations of qualified candidates of all
genders, cultural, ethnic, and racial groups, people with disabilities,
and individuals who may belong to other underrepresented groups. The
Department also seeks geographic diversity in the composition of the
Committee. Appointment to this Committee shall be made without
discrimination on the basis of age, race, ethnicity, gender, sexual
orientation, disability, and cultural, religious, or socioeconomic
status. Requests for reasonable accommodation to enable participation
on the Committee should be indicated in the nomination submission.
Member Terms
Non-Federal public members of the Committee ``shall serve for a
term of 4 years, and may be reappointed for one additional 4-year term.
Any member appointed to fill a vacancy for an unexpired term shall be
appointed for the remainder of such term. A member [with a valid
appointment] may serve after the expiration of the member's term until
a successor has been appointed.''
Meetings and Travel
``The Committee shall meet at the call of the chairperson or upon
the request of the Secretary. The Committee shall meet not fewer than 2
times each year.''
In the years 2014-2019, the IACC held an average of 4 meetings, 1
workshop and 2 phone conferences per year, including full committee,
subcommittee, working and planning group meetings, and workshops.
Travel expenses are provided for non-federal public Committee members
to facilitate attendance at in-person meetings. Members are expected to
be committed to making every effort to attend all full committee
meetings and workshops in person and relevant subcommittee, working and
planning group meetings by phone. For those who occasionally cannot
travel or for individuals with a disability that prevents travel,
remote access options are provided.
Submission Instructions and Deadline
Nominations should include a cover letter of no longer than 3 pages
describing the candidate's interest in seeking appointment to the IACC,
including relevant personal and professional experience with ASD,
indication of any membership eligibility requirements met, disability
accommodation requests, and an indication of commitment to attend IACC
meetings if selected, as well as full contact information and a current
resume or curriculum vitae. Up to 2 letters of support are permitted in
addition to the nomination, with a page limit of 3 pages per letter.
Please do not include other materials unless requested.
Nominations are due by Friday January 17, 2020 and may be sent to
Dr. Susan Daniels, Director, Office of Autism Research Coordination/
NIMH/NIH, 6001 Executive Boulevard, Room 7220, Bethesda, Maryland 20892
by standard or express mail, or via email to
[email protected]. Confirmation of receipt will be
provided.
More information about the IACC is available at iacc.hhs.gov.
Dated: November 20, 2019.
Susan A. Daniels,
Director, Office of Autism Research Coordination, National Institute of
Mental Health, National Institutes of Health.
[FR Doc. 2019-25668 Filed 11-25-19; 8:45 am]
BILLING CODE 4140-01-P